NCT03624751Active, not recruiting
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
The prevalence of thyroid cancer has increased in recent decades. Patients with thyroid cancer need to choose between Thyrogen® injection and Eltroxin® withdrawal before radioiodine therapy or scan. This is a prospective, observational study, aiming to observe the difference of metabolic profiles between patients choose Thyrogen® injection and Eltroxin® withdrawal.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 107 (estimated)
- First submitted
- 24 May 2018
- Start date
- 6 Jun 2018
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Taichung Veterans General Hospital
- Diseases
- Thyroid cancer
- NCT number
- NCT03624751
What you commit to
- Study type: Observational
- Planned participants: 107
- From 6 Jun 2018 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients cannot cooperate with radioiodine therapy。
Other
- Patients cannot cooperate with blood test.。
Who the study is looking for
- Patients with diagnosis of thyroid cancer。
- Patients who need radioiodine therapy or scan。
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Division of Endocrinology and Metabolism in Taichung Veterans General Hospital Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.